{"id":"W4389056558","doi":"10.3390/curroncol30120734","title":"Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Sirtex Medical","keywords":"Atezolizumab; Medicine; Nivolumab; Bevacizumab; Internal medicine; Oncology; Hepatocellular carcinoma; Renal cell carcinoma; Adverse effect; Gastroenterology; Urology; Immunotherapy; Surgery; Cancer; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009336188,0.0001690912,0.000620062,0.0001781768,0.0000966331,0.0003390669,0.0002192377,0.000190064,0.0003708492],"category_scores_gemma":[0.001372843,0.0001157631,0.0004108385,0.0002179264,0.000202751,0.0002491225,0.0001680904,0.0003923123,0.0001111814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000385923,"about_ca_system_score_gemma":0.0003434733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004479809,"about_ca_topic_score_gemma":0.001071974,"domain_scores_codex":[0.9995474,0.0001577403,0.00006209041,0.0000836532,0.0001120948,0.00003697891],"domain_scores_gemma":[0.999195,0.0001629139,0.0003758291,0.00006073719,0.0000762331,0.0001292394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1037695,0.003356871,0.6341849,0.0004597085,0.001744791,0.0007804605,0.0001559045,0.002667255,0.06059526,0.00008444204,0.0004492193,0.1917517],"study_design_scores_gemma":[0.004811088,0.1161338,0.8552904,0.00005567847,0.0009926485,0.003208386,0.0001176669,0.004598243,0.011535,0.00007801019,0.003146767,0.00003236442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982191,0.001217887,0.00015302,0.00001979341,0.00001010899,0.00002723646,0.00005685147,0.000004809157,0.0002912215],"genre_scores_gemma":[0.9993223,0.0002658721,0.0001131849,0.00002762269,0.00001596357,0.00001538226,0.0001499399,0.00000170298,0.00008806464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009336188,"threshold_uncertainty_score":0.00493747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1132250690769036,"score_gpt":0.3432396328408399,"score_spread":0.2300145637639363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}